The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation (Q45237759)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2005
edit
Language Label Description Also known as
English
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation
scientific article published in January 2005

    Statements

    The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit